Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Other Operating Expenses (2020 - 2025)

Celularity (CELU) has disclosed Other Operating Expenses for 6 consecutive years, with $4.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses rose 0.52% to $4.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $21.3 million, a 528.9% increase, with the full-year FY2024 number at $16.5 million, down 87.65% from a year prior.
  • Other Operating Expenses was $4.3 million for Q3 2025 at Celularity, down from $5.6 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $87.1 million in Q3 2023 to a low of -$43.4 million in Q4 2022.
  • A 5-year average of $7.4 million and a median of $4.3 million in 2025 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: skyrocketed 9186.17% in 2021, then tumbled 443.38% in 2022.
  • Celularity's Other Operating Expenses stood at -$18.1 million in 2021, then tumbled by 140.08% to -$43.4 million in 2022, then soared by 67.76% to -$14.0 million in 2023, then soared by 153.76% to $7.5 million in 2024, then crashed by 43.13% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Other Operating Expenses are $4.3 million (Q3 2025), $5.6 million (Q2 2025), and $3.9 million (Q1 2025).